Skip to main content
. 2017 May 16;174(13):2043–2059. doi: 10.1111/bph.13803

Figure 7.

Figure 7

Pharmacokinetic profiles of isorhapontigenin in Sprague–Dawley rats. Rats were administered (A) 30 μmol·kg−1 isorhapontigenin i.v. or (B) 600 μmol·kg−1 isorhapontigenin p.o. Blood was collected at specific time points and plasma analysed using LC‐MS/MS. Data are presented as mean ± SEM (n = 5).

HHS Vulnerability Disclosure